{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T12:12:17Z","timestamp":1763727137913,"version":"3.45.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Left ventricular myocardial work (LVMW) represents an innovative tool based on echocardiography designed to assess left ventricular (LV) performance in conjunction with LV pressure patterns. Although previous studies have compared differences in LVMW among patients with Fabry disease (FD), cardiac amyloidosis (CA), and hypertension at rest, there is limited research on the characteristics of LVMW in patients with FD during exercise. This study aims to explore the characteristics of LVMW at rest and during exercise in patients with FD and the value of LVMW combined with stress echocardiography for the early detection of impaired cardiac function in subclinical Fabry patients. This cross-sectional study included 54 participants, comprising 23 healthy individuals and 31 patients with FD. All participants underwent comprehensive two-dimensional echocardiography and semi-supine exercise stress echocardiography tests. At rest, individuals with FD exhibited markedly lower LV global longitudinal strain (LVGLS), LV global myocardial constructive work (LVGCW), LV global myocardial work efficiency (LVGWE), and LV global myocardial work index (LVGWI) compared to healthy controls. During exercise, LVGLS, LVGWI, LVGCW, and LV global wasted myocardial work (LVGWW) markedly increased in patients with FD and controls, while LVGWE decreased. However, across the four phases (rest, 25 W, peak, and recovery), patients with FD consistently demonstrated lower LVGLS, LVGWI, LVGWE, and LVGCW compared to controls. Moreover, the rise in LVGWI and LVGCW from the rest phase to the peak stage was markedly smaller in individuals with FD than in controls. A moderate correlation was found between LVGWI and LVGWE with LV mass index (LVMI) in individuals with FD (LVGWI: r\u2009=\u2009\u2212\u00a00.57,\n                    <jats:italic>P<\/jats:italic>\n                    \u2009&lt;\u20090.05; LVGWE: r\u2009=\u2009\u2212\u00a00.68,\n                    <jats:italic>P<\/jats:italic>\n                    \u2009&lt;\u20090.001). Additionally, individuals with FD with LV hypertrophy (LVH) exhibited lower LVGLS, LVGWE, and LVGCW from the rest to peak than those without LVH. Individuals with FD who had normal LVGLS at rest or those without LVH still showed markedly lower LVGWI than controls during the resting phase. Additionally, at peak exercise, LVGLS, LVGWI, and LVGCW were diminished significantly in the individuals with FD relative to the control cohort. ROC curve analysis in both resting and exercising states showed that LVGWI (rest: AUC 0.86, sensitivity 87%, specificity 74%; peak: AUC\u00a00.94, sensitivity 71%, specificity 96%;) and LVGCW (rest: AUC 0.82, sensitivity 87%, specificity 70%; peak: AUC 0.92, sensitivity 84%, specificity 87%;) than LVGLS (resting: AUC 0.79, sensitivity 61%, specificity 87%; peak: AUC 0.88, sensitivity of 77%, and specificity of 87%) have a higher value in the diagnosis of FD. Patients with FD have markedly lower LVGWI, LVGWE, and LVGCW compared to the healthy controls, and these reductions are more prominent during exercise. Although LVGWI and LVGCW increase during exercise in patients with FD, the rate of increase is reduced, indicating impaired myocardial metabolism and energy utilization efficiency, especially in patients with FD with LVH. Additionally, LVMW combined with Stress Echocardiography allows early detection of impaired cardiac function in Fabry patients.\n                  <\/jats:p>","DOI":"10.1038\/s41598-025-25382-w","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T11:55:25Z","timestamp":1763726125000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Left ventricular myocardial work combined with stress echocardiography assessment of cardiac function in patients with Fabry disease"],"prefix":"10.1038","volume":"15","author":[{"given":"Hong","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zijie","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenrui","family":"Ai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yajing","family":"Miao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaojie","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingchao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Songyun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongning","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,21]]},"reference":[{"key":"25382_CR1","doi-asserted-by":"publisher","first-page":"338","DOI":"10.7326\/0003-4819-138-4-200302180-00014","volume":"138","author":"J Robert","year":"2003","unstructured":"Robert, J., Brady, R., Barranger, J., Collins, A. J. & Germain, D. P. Fabry disease, an under-recognized multisystemic disorder: Expert recommendations for diagnosis, management, and enzyme replacement therapy. Ann. Internal Medi. 138, 338\u2013346. https:\/\/doi.org\/10.7326\/0003-4819-138-4-200302180-00014 (2003).","journal-title":"Ann. Internal Medi."},{"key":"25382_CR2","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.jacc.2020.12.024","volume":"77","author":"M Pieroni","year":"2021","unstructured":"Pieroni, M. et al. Cardiac involvement in Fabry Disease: JACC review topic of the week. J. Am. Coll. Cardiol. 77, 922\u2013936. https:\/\/doi.org\/10.1016\/j.jacc.2020.12.024 (2021).","journal-title":"J. Am. Coll. Cardiol."},{"key":"25382_CR3","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1136\/jmg.2008.065904","volume":"46","author":"A Mehta","year":"2009","unstructured":"Mehta, A. et al. Natural course of Fabry disease: Changing pattern of causes of death in FOS - Fabry Outcome Survey. J. Med. Genet. 46, 548\u2013552. https:\/\/doi.org\/10.1136\/jmg.2008.065904 (2009).","journal-title":"J. Med. Genet."},{"key":"25382_CR4","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1097\/GIM.0b013e3181bb05bb","volume":"11","author":"S Waldek","year":"2009","unstructured":"Waldek, S., Patel, M. R., Banikazemi, M., Lemay, R. & Lee, P. Life expectancy and cause of death in males and females with Fabry disease: Findings from the Fabry Registry. Genet. Med. 11, 790\u2013796. https:\/\/doi.org\/10.1097\/GIM.0b013e3181bb05bb (2009).","journal-title":"Genet. Med."},{"key":"25382_CR5","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1016\/j.jcmg.2018.11.039","volume":"12","author":"R Perry","year":"2019","unstructured":"Perry, R. et al. The role of cardiac imaging in the diagnosis and management of Anderson-Fabry disease. JACC: Cardiovasc. Imaging 12, 1230\u20131242. https:\/\/doi.org\/10.1016\/j.jcmg.2018.11.039 (2019).","journal-title":"JACC: Cardiovasc. Imaging"},{"key":"25382_CR6","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1093\/eurheartj\/ehs016","volume":"33","author":"K Russell","year":"2012","unstructured":"Russell, K. et al. A novel clinical method for quantification of regional left ventricular pressure\u2013strain loop area: A non-invasive index of myocardial work. Eur. Heart J. 33, 724\u2013733. https:\/\/doi.org\/10.1093\/eurheartj\/ehs016 (2012).","journal-title":"Eur. Heart J."},{"key":"25382_CR7","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1161\/CIRCIMAGING.122.014419","volume":"16","author":"N Marzlin","year":"2023","unstructured":"Marzlin, N. et al. Myocardial work in echocardiography. Circ. Cardiovasc. Imaging 16, 198\u2013214. https:\/\/doi.org\/10.1161\/CIRCIMAGING.122.014419 (2023).","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"25382_CR8","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.echo.2019.02.014","volume":"32","author":"NFA Edwards","year":"2019","unstructured":"Edwards, N. F. A. et al. Global myocardial work is superior to global longitudinal strain to predict significant coronary artery disease in patients with normal left ventricular function and wall motion. J. Am. Soc. Echocardiogr. 32, 947\u2013957. https:\/\/doi.org\/10.1016\/j.echo.2019.02.014 (2019).","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"25382_CR9","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1016\/j.jcmg.2022.02.027","volume":"15","author":"O Calvillo-Arguelles","year":"2022","unstructured":"Calvillo-Arguelles, O. et al. Diagnostic and prognostic value of myocardial work indices for identification of cancer therapy-related cardiotoxicity. JACC Cardiovasc. Imaging 15, 1361\u20131376. https:\/\/doi.org\/10.1016\/j.jcmg.2022.02.027 (2022).","journal-title":"JACC Cardiovasc. Imaging"},{"key":"25382_CR10","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/j.echo.2023.07.002","volume":"36","author":"A Moya","year":"2023","unstructured":"Moya, A., Buytaert, D., Penicka, M., Bartunek, J. & Vanderheyden, M. State-of-the-Art: Noninvasive assessment of left ventricular function through myocardial work. J. Am. Soc. Echocardiogr. 36, 1027\u20131042. https:\/\/doi.org\/10.1016\/j.echo.2023.07.002 (2023).","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"25382_CR11","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1007\/s10554-020-02105-y","volume":"37","author":"L Spinelli","year":"2020","unstructured":"Spinelli, L. et al. Does left ventricular function predict cardiac outcome in Anderson-Fabry disease?. Int. J. Cardiovasc. Imaging 37, 1225\u20131236. https:\/\/doi.org\/10.1007\/s10554-020-02105-y (2020).","journal-title":"Int. J. Cardiovasc. Imaging"},{"key":"25382_CR12","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1093\/eurheartj\/ehn492","volume":"30","author":"R Sicari","year":"2008","unstructured":"Sicari, R. et al. Stress echocardiography expert consensus statement-executive summary: European association of echocardiography (EAE) (a registered branch of the ESC). Eur. Heart J. 30, 278\u2013289. https:\/\/doi.org\/10.1093\/eurheartj\/ehn492 (2008).","journal-title":"Eur. Heart J."},{"key":"25382_CR13","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.echo.2016.10.016","volume":"30","author":"P Lancellotti","year":"2017","unstructured":"Lancellotti, P. et al. The clinical use of stress echocardiography in non-ischaemic heart disease: Recommendations from the European Association of cardiovascular imaging and the American society of echocardiography. J. Am. Soc. Echocardiogr. 30, 101\u2013138. https:\/\/doi.org\/10.1016\/j.echo.2016.10.016 (2017).","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"25382_CR14","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1016\/j.jcmg.2017.07.016","volume":"10","author":"EJ Rowin","year":"2017","unstructured":"Rowin, E. J., Maron, B. J., Olivotto, I. & Maron, M. S. Role of exercise testing in hypertrophic cardiomyopathy. JACC Cardiovasc. Imaging 10, 1374\u20131386. https:\/\/doi.org\/10.1016\/j.jcmg.2017.07.016 (2017).","journal-title":"JACC Cardiovasc. Imaging"},{"key":"25382_CR15","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1007\/s10554-023-02818-w","volume":"39","author":"J Fan","year":"2023","unstructured":"Fan, J., Ma, C., Wang, H. & Zhou, B. The value of myocardial work in patients with left ventricular hypertrophy. Int. J. Cardiovasc. Imaging 39, 1105\u20131113. https:\/\/doi.org\/10.1007\/s10554-023-02818-w (2023).","journal-title":"Int. J. Cardiovasc. Imaging"},{"key":"25382_CR16","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1093\/ehjci\/jev014","volume":"16","author":"RM Lang","year":"2015","unstructured":"Lang, R. M. et al. Recommendations for cardiac chamber quantification by echocardiography in adults: An update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur. Heart J. Cardiovasc. Imaging 16, 233\u2013270. https:\/\/doi.org\/10.1093\/ehjci\/jev014 (2015).","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"25382_CR17","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1016\/S0140-6736(08)61589-5","volume":"372","author":"YA Zarate","year":"2008","unstructured":"Zarate, Y. A. & Hopkin, R. J. Fabry\u2019s disease. Lancet 372, 1427\u20131435. https:\/\/doi.org\/10.1016\/S0140-6736(08)61589-5 (2008).","journal-title":"Lancet"},{"key":"25382_CR18","doi-asserted-by":"publisher","first-page":"2027852","DOI":"10.1080\/19490976.2022.2027852","volume":"14","author":"M Lenders","year":"2022","unstructured":"Lenders, M. & Brand, E. Fabry disease\u2014A multisystemic disease with gastrointestinal manifestations. Gut. Microbes 14, 2027852. https:\/\/doi.org\/10.1080\/19490976.2022.2027852 (2022).","journal-title":"Gut. Microbes"},{"key":"25382_CR19","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s11897-024-00645-1","volume":"21","author":"D Weissman","year":"2024","unstructured":"Weissman, D., Dudek, J., Sequeira, V. & Maack, C. Fabry disease: Cardiac implications and molecular mechanisms. Curr. Heart Fail. Rep. 21, 81\u2013100. https:\/\/doi.org\/10.1007\/s11897-024-00645-1 (2024).","journal-title":"Curr. Heart Fail. Rep."},{"key":"25382_CR20","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1136\/heartjnl-2024-325300","volume":"111","author":"J Canada","year":"2025","unstructured":"Canada, J. & Trankle, C. Cardiopulmonary exercise testing in Fabry disease: Is it an early marker of cardiomyopathy?. Heart 111, 193\u2013194. https:\/\/doi.org\/10.1136\/heartjnl-2024-325300 (2025).","journal-title":"Heart"},{"key":"25382_CR21","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1136\/heartjnl-2024-324553","volume":"111","author":"A Roy","year":"2025","unstructured":"Roy, A. et al. Changes in peak oxygen consumption in Fabry disease and associations with cardiomyopathy severity. Heart 111, 230\u2013238. https:\/\/doi.org\/10.1136\/heartjnl-2024-324553 (2025).","journal-title":"Heart"},{"key":"25382_CR22","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1093\/ehjci\/jeab214","volume":"23","author":"D-Y Lu","year":"2022","unstructured":"Lu, D.-Y. et al. Reduced global longitudinal strain as a marker for early detection of Fabry cardiomyopathy. Eur. Heart J. Cardiovasc. Imaging 23, 487\u2013495. https:\/\/doi.org\/10.1093\/ehjci\/jeab214 (2022).","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"25382_CR23","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1093\/ehjci\/jead121","volume":"24","author":"J Marek","year":"2023","unstructured":"Marek, J. et al. Three-dimensional echocardiographic left ventricular strain analysis in Fabry disease: Correlation with heart failure severity, myocardial scar, and impact on long-term prognosis. Eur. Heart J. Cardiovasc. Imaging 24, 1629\u20131637. https:\/\/doi.org\/10.1093\/ehjci\/jead121 (2023).","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"25382_CR24","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1093\/ehjci\/jey108","volume":"20","author":"R Esposito","year":"2019","unstructured":"Esposito, R. et al. Prominent longitudinal strain reduction of left ventricular basal segments in treatment-naive Anderson-Fabry disease patients. Eur. Heart J. Cardiovasc. Imaging 20, 438\u2013445. https:\/\/doi.org\/10.1093\/ehjci\/jey108 (2019).","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"25382_CR25","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/j.echo.2020.05.004","volume":"33","author":"J Chan","year":"2020","unstructured":"Chan, J., Edwards, N. F. A., Scalia, G. M. & Khandheria, B. K. Myocardial work: A new type of strain imaging?. J. Am. Soc. Echocardiogr. 33, 1209\u20131211. https:\/\/doi.org\/10.1016\/j.echo.2020.05.004 (2020).","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"25382_CR26","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1007\/s10741-021-10119-4","volume":"27","author":"D Abawi","year":"2022","unstructured":"Abawi, D. et al. The non-invasive assessment of myocardial work by pressure-strain analysis: Clinical applications. Heart Fail. Rev. 27, 1261\u20131279. https:\/\/doi.org\/10.1007\/s10741-021-10119-4 (2022).","journal-title":"Heart Fail. Rev."},{"key":"25382_CR27","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.echo.2021.04.013","volume":"34","author":"S Roemer","year":"2021","unstructured":"Roemer, S. et al. The utility of myocardial work in clinical practice. J. Am. Soc. Echocardiogr. 34, 807\u2013818. https:\/\/doi.org\/10.1016\/j.echo.2021.04.013 (2021).","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"25382_CR28","doi-asserted-by":"publisher","first-page":"e008872","DOI":"10.1161\/circimaging.119.008872","volume":"12","author":"KD Knott","year":"2019","unstructured":"Knott, K. D. et al. Quantitative myocardial perfusion in Fabry disease. Circ. Cardiovasc. Imaging 12, e008872. https:\/\/doi.org\/10.1161\/circimaging.119.008872 (2019).","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"25382_CR29","doi-asserted-by":"publisher","first-page":"oeae041","DOI":"10.1093\/ehjopen\/oeae041","volume":"4","author":"T Steudel","year":"2024","unstructured":"Steudel, T. et al. Diagnostic value of left ventricular layer strain and specific regional strain patterns in cardiac amyloidosis and Fabry disease. Eur. Heart J. Open 4, oeae041. https:\/\/doi.org\/10.1093\/ehjopen\/oeae041 (2024).","journal-title":"Eur. Heart J. Open"},{"key":"25382_CR30","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.echo.2018.06.010","volume":"31","author":"AH Larsen","year":"2018","unstructured":"Larsen, A. H., Clemmensen, T. S., Wiggers, H. & Poulsen, S. H. Left ventricular myocardial contractile reserve during exercise stress in healthy adults: A two-dimensional speckle-tracking echocardiographic study. J. Am. Soc. Echocardiogr. 31, 1116-1126.e1111. https:\/\/doi.org\/10.1016\/j.echo.2018.06.010 (2018).","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"25382_CR31","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.ijcard.2017.06.079","volume":"248","author":"A Frustaci","year":"2017","unstructured":"Frustaci, A., Chimenti, C., Doheny, D. & Desnick, R. J. Evolution of cardiac pathology in classic Fabry disease: Progressive cardiomyocyte enlargement leads to increased cell death and fibrosis, and correlates with severity of ventricular hypertrophy\u202c\u202c\u202c\u202c\u202c\u202c\u202c\u202c. Int J Cardiol 248, 257\u2013262. https:\/\/doi.org\/10.1016\/j.ijcard.2017.06.079 (2017).","journal-title":"Int J Cardiol"},{"key":"25382_CR32","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12968-022-00859-z","volume":"24","author":"A Ponsiglione","year":"2022","unstructured":"Ponsiglione, A. et al. Cardiovascular magnetic resonance native T1 mapping in Anderson-Fabry disease: A systematic review and meta-analysis. J. Cardiovasc. Magn. Reson. 24, 31. https:\/\/doi.org\/10.1186\/s12968-022-00859-z (2022).","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"25382_CR33","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.echo.2024.04.010","volume":"37","author":"HC Chang","year":"2024","unstructured":"Chang, H. C., Kuo, L., Sung, S. H., Niu, D. M. & Yu, W. C. Prognostic implications of left ventricular hypertrophy and mechanical function in Fabry disease: A longitudinal cohort study. J. Am. Soc. Echocardiogr. 37, 787\u2013796. https:\/\/doi.org\/10.1016\/j.echo.2024.04.010 (2024).","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"25382_CR34","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.ymgme.2015.10.007","volume":"117","author":"RJ Hopkin","year":"2016","unstructured":"Hopkin, R. J. et al. The management and treatment of children with Fabry disease: A United States-based perspective. Mol. Genet. Metab. 117, 104\u2013113. https:\/\/doi.org\/10.1016\/j.ymgme.2015.10.007 (2016).","journal-title":"Mol. Genet. Metab."},{"key":"25382_CR35","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13023-015-0253-6","volume":"10","author":"M Biegstraaten","year":"2015","unstructured":"Biegstraaten, M. et al. Recommendations for initiation and cessation of enzyme replacement therapy in patients with Fabry disease: The European Fabry Working Group consensus document. Orphanet J. Rare Dis. 10, 36. https:\/\/doi.org\/10.1186\/s13023-015-0253-6 (2015).","journal-title":"Orphanet J. Rare Dis."},{"key":"25382_CR36","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1093\/eurheartj\/ehae148","volume":"45","author":"M Pieroni","year":"2024","unstructured":"Pieroni, M., Namdar, M., Olivotto, I. & Desnick, R. J. Anderson-Fabry disease management: role of the cardiologist. Eur. Heart J. 45, 1395\u20131409. https:\/\/doi.org\/10.1093\/eurheartj\/ehae148 (2024).","journal-title":"Eur. Heart J."},{"key":"25382_CR37","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1136\/jmg-2022-108768","volume":"60","author":"A Camporeale","year":"2023","unstructured":"Camporeale, A. et al. Effect of migalastat on cardiac involvement in Fabrry disease: MAIORA study. J. Med. Genet. 60, 850\u2013858. https:\/\/doi.org\/10.1136\/jmg-2022-108768 (2023).","journal-title":"J. Med. Genet."},{"key":"25382_CR38","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.jacc.2022.06.022","volume":"80","author":"C Orsborne","year":"2022","unstructured":"Orsborne, C. et al. Validated model for prediction of adverse cardiac outcome in patients with fabry disease. J. Am. Coll. Cardiol. 80, 982\u2013994. https:\/\/doi.org\/10.1016\/j.jacc.2022.06.022 (2022).","journal-title":"J. Am. Coll. Cardiol."},{"key":"25382_CR39","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1007\/s10741-024-10423-9","volume":"29","author":"MC Pastore","year":"2024","unstructured":"Pastore, M. C. et al. Stress echocardiography in heart failure patients: additive value and caveats. Heart Fail. Rev. 29, 1117\u20131133. https:\/\/doi.org\/10.1007\/s10741-024-10423-9 (2024).","journal-title":"Heart Fail. Rev."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25382-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25382-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25382-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T11:55:26Z","timestamp":1763726126000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25382-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,21]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["25382"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-25382-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,21]]},"assertion":[{"value":"5 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"41356"}}